| 产品详情 |
| Edit |   |
|---|
| Product Name | NME3, Recombinant, Human, aa22-169, His-Tag |
|---|
| Description | Purity ~95% (SDS-PAGE). NME3, also known as, a potential suppressor of metastasis, is expressed at a much lower level in highly metastatic cells than in cells with lower metastatic potential. It is important for the synthesis of nucleoside triphosphates and may play a role in apoptosis induction and hematopoiesis. It is preferentially expressed during early stages of myeloid differentiation of highly purified CD34+ cells. Source: Recombinant protein corresponding to aa22-169 from human NME3, fused to His-tag at N-terminal expressed in E. coli. Molecular Weight: ~19.1kD (169aa) Specific Activity: >150units/mg, and is defined as the amount of enzyme that convert 1umole each of ATP and TDP to ADP and TTP/minute at pH 7.5 at 25°C in a couple system with PK/LDH. AA |
|---|
| Size | 20ug, 100ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | NME3, Recombinant, Human, aa22-169, His-Tag(Nucleoside diphosphate Kinase 3, c371H6.2, DR-nm23, KIAA0516, NDPK-C, NDPKC, NM23-H3, NM23H3) |
|---|
| Gene, Accession, CAS # | Accession: NP_002504 |
|---|
| Catalog # | 351395 |
|---|
| Price | |
|---|
| Order / More Info | NME3, Recombinant, Human, aa22-169, His-Tag from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|